MedTrace Logo

Low-Dose Caffeine and Taurine Effects on Performance

NCT07466654 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2026-03-12

No results posted yet for this study

Summary

This study aims to investigate the effects of low-dose caffeine and taurine, administered separately and in combination, on anaerobic, neuromuscular, and cognitive performance. The study is designed as a randomized, double-blind, placebo-controlled crossover trial involving trained man participants. Each participant will complete experimental sessions under different supplementation conditions, including caffeine, taurine, their combination, and placebo. Performance outcomes will include anaerobic power, neuromuscular performance, and cognitive function assessments. The findings will help clarify whether the combined ingestion of caffeine and taurine produces synergistic performance effects compared with isolated supplementation.

Conditions

  • Anaerobic Performance Neuromuscular Performance Cognitive Performance

Interventions

DIETARY_SUPPLEMENT

Caffeine

Caffeine administered at a dose of 2 mg/kg body mass in capsule form, 60 minutes prior to performance testing.

DIETARY_SUPPLEMENT

taurine

Taurine administered at a dose of 10 mg/kg body mass in capsule form, 60 minutes prior to performance testing.

DIETARY_SUPPLEMENT

Caffeine + Taurine

Combined supplementation of caffeine (2 mg/kg) and taurine (10 mg/kg) administered 60 minutes prior to testing.

DIETARY_SUPPLEMENT

Placebo

Placebo capsule containing maltodextrin (300 mg) administered 60 minutes prior to testing.

Sponsors & Collaborators

  • Burdur Mehmet Akif Ersoy University

    collaborator OTHER

  • Ankara University

    lead OTHER

Principal Investigators

  • Yakup Köse, MsC · Burdur Mehmet Akif Ersoy University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-15
Primary Completion
2025-11-15
Completion
2025-11-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07466654 on ClinicalTrials.gov